These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 16281833

  • 1. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
    Karaguzhin SG, Merinov DS, Martov AG.
    Urologiia; 2005; (5):17-21. PubMed ID: 16281833
    [Abstract] [Full Text] [Related]

  • 2. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [Abstract] [Full Text] [Related]

  • 3. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW.
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [Abstract] [Full Text] [Related]

  • 4. Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guérin immunotherapy?
    Gofrit ON, Pode D, Pizov G, Zorn KC, Katz R, Shapiro A.
    BJU Int; 2009 Apr; 103(7):905-8. PubMed ID: 19021623
    [Abstract] [Full Text] [Related]

  • 5. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 6. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
    Ugurlu O, Gonulalan U, Adsan O, Kosan M, Oztekin V, Cetinkaya M.
    Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy of transurethral resection of the prostate in the patients with weak bladder contractility index.
    Han DH, Jeong YS, Choo MS, Lee KS.
    Urology; 2008 Apr; 71(4):657-61. PubMed ID: 18313105
    [Abstract] [Full Text] [Related]

  • 9. [Cystectomy or transurethral resection in the treatment of bladder carcinoma].
    Flamm J, Kiesswetter H, Burkert S.
    Z Urol Nephrol; 1982 Oct; 75(10):729-37. PubMed ID: 7158092
    [Abstract] [Full Text] [Related]

  • 10. A re-staging transurethral resection predicts early progression of superficial bladder cancer.
    Herr HW, Donat SM.
    BJU Int; 2006 Jun; 97(6):1194-8. PubMed ID: 16566813
    [Abstract] [Full Text] [Related]

  • 11. [Results of monopolar versus quasibipolar transurethral resection of the prostate and urinary bladder].
    Popov SV, Novikov AI, Burlaka OO, Viazovtsev PV.
    Urologiia; 2012 Jun; (3):38, 40-1. PubMed ID: 23074932
    [Abstract] [Full Text] [Related]

  • 12. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
    Komiakov BK, Gorelov SI, Novikov AI, Gorelov AI, Novikov PB, Strokova LA, Al-Atar T.
    Urologiia; 2004 Jun; (6):37-40. PubMed ID: 15719729
    [Abstract] [Full Text] [Related]

  • 13. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Surgery (TUR-P) as a recommended initial treatment modality for the presented case].
    Gotoh M.
    Hinyokika Kiyo; 2005 Sep; 51(9):603-8. PubMed ID: 16229373
    [Abstract] [Full Text] [Related]

  • 16. [Transurethral endoscopic dissection of the bladder neck and prostate].
    Martov AG, Gorilovskiĭ ML, Kamalov AA, Gushchin BL.
    Urol Nefrol (Mosk); 1995 Sep; (4):29-31. PubMed ID: 7571198
    [Abstract] [Full Text] [Related]

  • 17. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [Abstract] [Full Text] [Related]

  • 18. Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function.
    Davila HH, Weber T, Burday D, Thurman S, Carrion R, Salup R, Lockhart JL.
    BJU Int; 2007 Nov; 100(5):1026-9. PubMed ID: 17868423
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
    Margel D, Tal R, Golan S, Kedar D, Engelstein D, Baniel J.
    Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
    [Abstract] [Full Text] [Related]

  • 20. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
    Tanaka Y, Aoyama H, Momose H, Ono T, Samma S, Tanaka N, Akiyama T, Tani Y, Masuda Y, Matsuki H, Tani M, Tanaka M.
    Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.